Aveanna Healthcare AVAH
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 78th percentile, 5-year average -88.1x
#421 of 2993 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 84th percentile, 5-year average 2.0x
#4763 of 5330 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 94th percentile, 5-year average 0.4x
#1608 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 7.44 | – | 2.04 | 84% (pricier than usual) | #4763 of 5330 (1 = cheapest) |
| PE | 8.21 | 13.02 | -88.09 | 78% (pricier than usual) | #421 of 2993 (1 = cheapest) |
| PS | 0.94 | 0.87 | 0.45 | 94% (pricier than usual) | #1608 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on AVAH.
Sign in to join the discussion.